Continuous Positive Airway Pressure (CPAP) Promotion And Prognosis - the Army Sleep Apnea Program (ASAP)

Completed · Phase 4 · Has a placebo group

Conditions studied: Obstructive Sleep Apnea

In brief

The purpose of this study is to assess the efficacy of Eszopiclone in improving short and intermediate-term compliance with continuous positive airway pressure (CPAP) in patients newly diagnosed with obstructive sleep apnea (OSA).

Key facts

Study ID

NCT00612157

Run by

Walter Reed Army Medical Center

People needed

154

Starts

2008-01-01

Expected to finish

2009-02-01

Last updated by the study team

2009-02-26

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients
• Newly diagnosed with OSA who are prescribed CPAP therapy

You may not qualify if…

• Patients < 18 years old
• Patients over 65 years
• Pregnant women
• Patients with chronic liver disease
• Patients who abuse alcohol
• Patients taking narcotics or using sedative-hypnotic agents such as Ambien, Klonopin or Benadryl

Where it is running

• Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.